Daily FNArena News

In the wake of Telix Pharmaceuticals’ non-IPO on the Nasdaq, FNArena shines a light on the company’s fortunes and that of Australian biotech and cancer research generally

Michael Gable of Fairmont Equities sees Fortescue shares recovering from current oversold conditions

Analysts highlight structural tailwinds for Ventia Services and margin protection from contract mix and flexible costs

Independent Investment Research updates developments among Australia’s listed investment companies and provides comparative data

At a time when brokers are increasing gold price forecasts, new Bellevue Gold research highlights significant upside from resource extensions, exploration, and a potential mill expansion

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

Following its near-death experience last year, BNPL provider Zip Co has made a strong comeback. Evans & Partners has initiated coverage

Superloop management has raised FY24 earnings guidance and confirmed the Origin Energy customer transition is on track. Analysts see additional growth opportunities

Pepperstone’s Chris Weston notes the S&P500 hitting 5500 and the Nasdaq100 into 20k are two huge milestone for these well-traded indices, but where to from here?

FY24 offered Ai and share market polarisation, but also a double digit return at the index level for the second year in a row